(Press-News.org)
A recent study published in Engineering has shed light on a novel combination therapy for rheumatoid arthritis (RA) that significantly reduces bone destruction by targeting the m6A methylation pathway. The research, conducted by a team from the China–Japan Friendship Clinical Medical College and other institutions, explores the synergistic effects of triptolide (TP) and medicarpin (Med) in mitigating RA-associated bone erosion.
Rheumatoid arthritis is a progressive autoimmune disease characterized by chronic inflammation and bone destruction, primarily driven by the overactivation of osteoclasts (OCs). Current treatments often fail to reverse existing joint damage and can be accompanied by significant side effects. This study investigates the potential of combining TP, a potent anti-inflammatory compound with a narrow therapeutic window, and Med, a flavonoid with anti-inflammatory and anti-bone destruction properties, to enhance efficacy and reduce toxicity.
The researchers utilized a collagen-induced arthritis (CIA) rat model to evaluate the effects of TP, Med, and their combination on disease progression and bone erosion. The results showed that the combination therapy significantly alleviated arthritis symptoms and delayed disease onset. Specifically, the combined treatment of TP and Med at half the doses of their monotherapies demonstrated superior efficacy in reducing bone erosion and inhibiting osteoclastogenesis compared to either drug alone.
Micro-CT scans and histological analyses revealed that the combination treatment effectively reduced bone surface-to-volume ratios and increased bone volume in the ankle and knee joints of CIA rats. Additionally, tartrate-resistant acid phosphatase (TRAP) staining and F-actin ring assays indicated that the combination therapy significantly decreased the number and function of OCs, highlighting its potential in inhibiting bone resorption.
The study further explored the molecular mechanisms underlying the synergistic effects of TP and Med. The researchers identified that TP and Med modulate the m6A methylation pathway by targeting methyltransferase-like 3 (METTL3) and YT521-B homology domain family protein 1 (YTHDF1), respectively. METTL3 is an m6A methyltransferase that promotes the methylation of OC-related mRNAs, while YTHDF1 is an m6A reader protein that enhances their translation and stability. The combination of TP and Med effectively disrupted this pathway, leading to decreased expression of key OC-related genes such as Nfatc1, c-Fos, Dc-stamp, Atp6v0d2, and Ctsk.
To validate these findings, the researchers conducted in vitro experiments using primary bone marrow mononuclear cells (BMMs) from mice. The results confirmed that TP and Med inhibited receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclastogenesis and bone resorption in a dose-dependent manner. Moreover, RNA immunoprecipitation (RIP) assays demonstrated that METTL3 and YTHDF1 directly interact with OC-related mRNAs, providing further evidence of their role in regulating osteoclastogenesis.
The study also examined the effects of TP and Med on the inflammatory response in CIA rats. The combination therapy was found to modulate the levels of pro-inflammatory and anti-inflammatory cytokines, with significant reductions in IL-1β and IL-6 levels. Additionally, the treatment helped replenish regulatory T cells (Tregs) in the spleen, which play a crucial role in maintaining bone tissue homeostasis.
This study provides compelling evidence that the combination of TP and Med offers a promising therapeutic strategy for RA by targeting the m6A methylation pathway. The findings highlight the potential of METTL3 and YTHDF1 as novel therapeutic targets and underscore the importance of exploring combination therapies to enhance treatment efficacy and reduce side effects. Future research may focus on optimizing dosing regimens and further elucidating the mechanisms of action to translate these findings into clinical practice.
The paper “Increased Alleviation of Bone Destruction in Individuals with Rheumatoid Arthritis via the Coinhibition of the METTL3 and YTHDF1 Axis by the Combination of Triptolide and Medicarpin,” is authored by Yi Jiao, Zhaoran Wang, Wenya Diao, Qishun Geng, Xing Wang, Xiaoxue Cao, Tong Shi, Jiahe Xu, Lu Zhao, Zihan Wang, Tiantian Deng, Lei Yang, Tingting Deng, Cheng Xiao. Full text of the open access paper: https://doi.org/10.1016/j.eng.2025.03.014. For more information about Engineering, visit the website at https://www.sciencedirect.com/journal/engineering.
END
Global climate change has become one of the most pressing challenges of the 21st century. As anthropogenic CO2 emissions from fossil fuel consumption and industrial processes continue to disrupt Earth’s carbon cycle, atmospheric CO2 concentrations have reached unprecedented levels—exceeding 420 parts per million (ppm) in 2023 compared to pre-industrial 280 ppm. This rapid accumulation of greenhouse gases has resulted in measurable consequences including rising global temperatures, ocean acidification, and increased frequency of extreme weather events.
As ...
The candidate pool for engineered materials that can help enable tomorrow's cutting-edge optical technologies—such as lasers, detectors and imaging devices—is much deeper than previously believed.
That's according to new research from the University of Michigan that examined a class of materials known as topological insulators. These materials have exciting and tunable properties when it comes to how they transit energy and information.
"We see this as a step toward building a more versatile and ...
It is of vital importance to, on occasion, consider how little we know about the spinning rock we all live on. Take coral reefs, for example. Given how much they’ve been studied, you’d think we’ve learned just about everything about them by now. But talk to a marine biologist, and they will quickly disabuse you of this notion.
“A majority of the things that are out there on coral reefs are simply unknown to us or haven’t been formally described or named,” said Catherine McFadden, a professor of life sciences at Harvey Mudd College.
McFadden is ...
In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations in mitochondrial DNA using a genetic tool known as a base editor. The results, published June 24th in the open-access journal PLOS Biology, offer new hope for people with rare genetic conditions.
Mitochondria, often called the powerhouses of the cell, have their own small set of DNA. Mutations in this mitochondrial DNA can lead to a wide range of maternally inherited diseases, cancer, and aging-related conditions. ...
The transition from sprawling (reptile-like) to more upright (parasagittal) posture and locomotion was a transformative event in mammalian evolution. A study published June 24th in the open-access journal PLOS Biology by Dr. Robert Brocklehurst and Professor Stephanie Pierce at Harvard University, USA and colleagues suggests that parasagittal posture evolved via an indirect, dynamic, and radiating process.
Non-mammalian synapsids (tetrapod vertebrates), the ancestors of extant mammals, underwent major musculoskeletal reorganization, including ...
A trade-off between tooth size and jaw mobility has restricted fish evolution, Nick Peoples at the University of California Davis, US, and colleagues report June 24th in the open-access journal PLOS Biology.
Ray-finned fish are a diverse and widespread group, representing 99% of living fish species. Two key adaptations have helped them thrive: large teeth and extendible jaws. Fish with larger teeth can access a wider range of food sources, while the ability to rapidly extend the upper jaw allows fish to hunt fast-swimming prey by using suction forces to pull them closer. However, these two innovations are rarely found in the same fish species. To find out why, ...
Researchers have discovered two new viruses in bats that are closely related to the deadly Nipah and Hendra viruses — pathogens that can cause severe brain inflammation and respiratory disease in humans. The viruses, as well as other new viruses, bacteria, and parasites identified from bat kidneys, were reported this week in the open-access journal PLOS Pathogens by Yun Feng of the Yunnan Institute of Endemic Disease Control and Prevention, China, and colleagues.
Bats are natural reservoirs for a wide range ...
For over a century, scientists have puzzled over a fundamental mystery in our evolutionary history: how did mammals go from sprawling like lizards to striding like cats and dogs? This transition—from a sprawled stance (like a lizard) to an upright (parasagittal) posture—marked a pivotal moment in mammal evolution. While the earliest non-mammalian synapsids, the ancestors of living mammals, had a sprawling posture, researchers debated when and how the upright postures of modern mammals evolved.
Now, a groundbreaking study in PLOS ...
An international research team led by Dr. André Marques from the Max Planck Institute for Plant Breeding Research in Cologne, Prof. Dr. Christiane Ritz from the Senckenberg Museum of Natural History in Görlitz and Dr. Aleš Kovařík from the Institute of Biophysics of the Czech Academy of Sciences has achieved a significant breakthrough in research into the reproduction of dogrose. The study, which has now been published in the renowned journal "Nature", shows how differences in the size of the centromeres - the central docking sites for chromosomes - play a decisive role in the extraordinary chromosome inheritance ...
ROCKVILLE, Md. – June 24, 2025 – The Association for Molecular Pathology, the premier global molecular diagnostic professional society, today announced the publication of best practice recommendations for clinical laboratories developing and performing homologous recombination deficiency (HRD) testing. The manuscript, titled “Recommendations for Clinical Molecular Laboratories for Detection of Homologous Recombination Deficiency in Cancer: A Joint Consensus Recommendation of the Association of Molecular Pathology, Association of Cancer ...
